Clinical Trial Update: Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Low-Tox vs Eox in locally advanced unresectable or metastatic gastric cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Unresectable Gastric Cancer

Drugs mentioned

• Eox
• Low-Tox

Snippet

Sponsor: Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | Conditions: Locally Advanced Unresectable Gastric Cancer, Metastatic Gastric Cancer | Phase 3 | Status: TERMINATED